cimetidine has been researched along with Coenuri Infection in 3 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Albendazole is considered the drug of choice for neurocysticercosis." | 9.08 | Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. ( Bonato, PS; Lanchote, VL; Marques, MP; Takayanagui, OM, 1997) |
| "A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease." | 7.69 | Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994) |
| "Albendazole is considered the drug of choice for neurocysticercosis." | 5.08 | Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. ( Bonato, PS; Lanchote, VL; Marques, MP; Takayanagui, OM, 1997) |
| "A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease." | 3.69 | Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dachman, WD | 1 |
| Adubofour, KO | 1 |
| Bikin, DS | 1 |
| Johnson, CH | 1 |
| Mullin, PD | 1 |
| Winograd, M | 1 |
| Takayanagui, OM | 1 |
| Lanchote, VL | 1 |
| Marques, MP | 1 |
| Bonato, PS | 1 |
| Overbosch, D | 1 |
1 review available for cimetidine and Coenuri Infection
| Article | Year |
|---|---|
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
1 trial available for cimetidine and Coenuri Infection
| Article | Year |
|---|---|
Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cimetidine; | 1997 |
1 other study available for cimetidine and Coenuri Infection
| Article | Year |
|---|---|
Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.
Topics: Adult; Anticonvulsants; Brain Diseases; Cimetidine; Cysticercosis; Drug Therapy, Combination; Humans | 1994 |